Piramal to buy 4 brands from Pfizer for Rs 110 cr

Piramal Enterprises’ consumer products division has entered into an agreement to acquire 4 brands from Pfizer for Rs 110 crore. These products currently operate in a market which is currently estimated at Rs 7,000 crore.

The acquired brands include Ferradol, Neko, Sloan’s and Waterbury’s Compound. Additionally the agreement also includes the trademark rights for Ferradol and Waterbury's Compound in Bangladesh and Sri Lanka, Piramal Enterprises said.

 Ferradol launched in 1982, is a leading nutritional supplement for children and adults. Neko launched in 1967, is a medicated soap indicated for body odour and minor skin infections.  

Sloan’s launched in 1982, is muscular pain reliever that is available in balm and liniment forms. Waterbury’s Compound launched in 1970, is used for building cough and cold immunity.

“We believe these brands from Pfizer will fit our portfolio and also strategically help us move closer towards our stated objective. The combination of growing our existing core brands and strategically acquiring accretive brands has helped us create a unique business which has a powerful portfolio of OTC brands in India,” Piramal Enterprises executive director Nandini Piramal said.

“We expect these brands to leverage the strong sales and distribution capability that we have built over the years and help us improve our profitability margins as there will be higher fixed cost absorption. These four powerful heritage brands have a huge potential to become power brands in their respective categories,” Piramal Enterprises consumer products division chief operating officer Kedar Rajadnye said.